(Q44169523)

30 November 2017

Fatal reactivation of hepatitis B virus following cytotoxic chemotherapy for acute myelogenous leukemia: fibrosing cholestatic hepatitis (English)

1 reference

30 November 2017

0 references

1 reference

1 reference

1 reference

Kojima H

1

1 reference

30 November 2017

Abei M

2

1 reference

30 November 2017

Takei N

3

1 reference

30 November 2017

Mukai Y

4

1 reference

30 November 2017

Hasegawa Y

5

1 reference

30 November 2017

Iijima T

6

1 reference

30 November 2017

Nagasawa T

7

1 reference

30 November 2017

1 August 2002

1 reference

European Journal of Haematology

30 November 2017

1 reference

30 November 2017

69

1 reference

30 November 2017

2

1 reference

30 November 2017

101-104

1 reference

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

30 November 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

Hepatitis B virus persistence after recovery from acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

Fibrosing cholestatic hepatitis: a report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

Treatment of fibrosing cholestatic hepatitis with lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

7 January 2021

High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

7 January 2021

Fibrosing cholestatic hepatitis after liver transplantation in a patient with hepatitis C and HIV infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

7 January 2021

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02719.X

7 January 2021

10.1034/J.1600-0609.2002.02719.X

Identifiers

DOI

1 reference

30 November 2017

1 reference